PolyPid Competitors and Similar CompaniesClear all
PolyPid's competitors and similar companies include VBI Vaccines and Meissa Vaccines.
 PolyPid PolyPid is a company developing a technology platform that enables a controlled and prolonged release of active pharmaceutical ingredients (API). |  VBI Vaccines VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. |  Meissa Vaccines Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus. | |
Founding Date | Founding Date 2008 | Founding Date 2001 | Founding Date 2014 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Petah Tikva, IL HQ Summit, US | Locations Cambridge, US HQ Ottawa, CA Rehovot, IL | Locations South San Francisco, US HQ Redwood City, US |
Employees | Employees 57 | Employees 12314% increase | Employees 3 |
Valuation ($) | Valuation ($) 23.7 m | Valuation ($) 1.9 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $8.7m (FY, 2023) | Revenue (est.) N/A |
Net income | Net income ($34.2m) (FY, 2025) | Net income ($92.8m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 103.8m | Total funding raised N/A | Total funding raised $ 33.4m |
For sources of this data, please see the company profile
View Company Profiles
VBI Vaccines
HQ
Cambridge, US
Employees
123↑ 14% increase
VBI Vaccines is a biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology.
View companyMeissa Vaccines
HQ
South San Francisco, US
Employees
3
Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as a respiratory syncytial virus.
View company